Anup Paul1,2, Surendra Kumar3, Anubhav Raj4, Abhinav A Sonkar4, Sudha Jain2, Atin Singhai5, Raja Roy6. 1. Centre of Biomedical Research, Formerly Centre of Biomedical Magnetic Resonance (CBMR), Sanjay Gandhi Postgraduate Institute of Medical Sciences Campus, Rae Bareli Road, Lucknow, 226014, India. 2. Department of Chemistry, University of Lucknow, University Road, Babuganj, Hasanganj, Lucknow, 226007, India. 3. Department of General Surgery, Kings George's Medical University (KGMU), Lucknow, 226003, India. dr_kukku@yahoo.co.in. 4. Department of General Surgery, Kings George's Medical University (KGMU), Lucknow, 226003, India. 5. Department of Pathology, King George's Medical University, Lucknow, 226003, India. 6. Centre of Biomedical Research, Formerly Centre of Biomedical Magnetic Resonance (CBMR), Sanjay Gandhi Postgraduate Institute of Medical Sciences Campus, Rae Bareli Road, Lucknow, 226014, India. roy@cbmr.res.in.
Abstract
INTRODUCTION: Breast cancer is the most frequent diagnosed cancer among women with a mortality rate of 15% of all cancer related deaths in women. Breast cancer is heterogeneous in nature and produces plethora of metabolites allowing its early detection using molecular diagnostic techniques like magnetic resonance spectroscopy. OBJECTIVES: To evaluate the variation in metabolic profile of breast cancer focusing on lipids as triglycerides (TG) and free fatty acids (FFA) that may alter in malignant breast tissues and lymph nodes from adjacent benign breast tissues by HRMAS 1H NMR spectroscopy. METHODS: The 1H NMR spectra recorded on 173 tissue specimens comprising of breast tumor tissues, adjacent tissues, few lymph nodes and overlying skin tissues obtained from 67 patients suffering from breast cancer. Multivariate statistical analysis was employed to identify metabolites acting as major confounders for differentiation of malignancy. RESULT: Reduction in lipid content were observed in malignant breast tissues along with a higher fraction of FFA. Four small molecule metabolites e.g., choline containing compounds (Chocc), taurine, glycine, and glutamate were also identified as major confounders. The test set for prediction provided sensitivity and specificity of more than 90% excluding the lymph nodes and skin tissues. CONCLUSION: Fatty acids composition in breast cancer using in vivo magnetic resonance spectroscopy (MRS) is gaining its importance in clinical settings (Coum et al. in Magn Reson Mater Phys Biol Med 29:1-4, 2016). The present study may help in future for precise evaluation of lipid classification including small molecules as a source of early diagnosis of invasive ductal carcinoma by employing in vivo magnetic resonance spectroscopic methods.
INTRODUCTION:Breast cancer is the most frequent diagnosed cancer among women with a mortality rate of 15% of all cancer related deaths in women. Breast cancer is heterogeneous in nature and produces plethora of metabolites allowing its early detection using molecular diagnostic techniques like magnetic resonance spectroscopy. OBJECTIVES: To evaluate the variation in metabolic profile of breast cancer focusing on lipids as triglycerides (TG) and free fatty acids (FFA) that may alter in malignant breast tissues and lymph nodes from adjacent benign breast tissues by HRMAS 1H NMR spectroscopy. METHODS: The 1H NMR spectra recorded on 173 tissue specimens comprising of breast tumor tissues, adjacent tissues, few lymph nodes and overlying skin tissues obtained from 67 patients suffering from breast cancer. Multivariate statistical analysis was employed to identify metabolites acting as major confounders for differentiation of malignancy. RESULT: Reduction in lipid content were observed in malignant breast tissues along with a higher fraction of FFA. Four small molecule metabolites e.g., choline containing compounds (Chocc), taurine, glycine, and glutamate were also identified as major confounders. The test set for prediction provided sensitivity and specificity of more than 90% excluding the lymph nodes and skin tissues. CONCLUSION:Fatty acids composition in breast cancer using in vivo magnetic resonance spectroscopy (MRS) is gaining its importance in clinical settings (Coum et al. in Magn Reson Mater Phys Biol Med 29:1-4, 2016). The present study may help in future for precise evaluation of lipid classification including small molecules as a source of early diagnosis of invasive ductal carcinoma by employing in vivo magnetic resonance spectroscopic methods.
Authors: Ilse M Schrover; Tim Leiner; Dennis W J Klomp; Jannie P Wijnen; Cuno S P M Uiterwaal; Wilko Spiering; Frank L J Visseren Journal: J Magn Reson Imaging Date: 2013-09-23 Impact factor: 4.813
Authors: John M Pearce; Mary C Mahoney; Jing-Huei Lee; Wen-Jang Chu; Kim M Cecil; Stephen M Strakowski; Richard A Komoroski Journal: MAGMA Date: 2012-10-05 Impact factor: 2.310
Authors: Eva Cífková; Michal Holčapek; Miroslav Lísa; David Vrána; Jiří Gatěk; Bohuslav Melichar Journal: Anal Bioanal Chem Date: 2014-10-29 Impact factor: 4.142
Authors: Beathe Sitter; Steinar Lundgren; Tone F Bathen; Jostein Halgunset; Hans E Fjosne; Ingrid S Gribbestad Journal: NMR Biomed Date: 2006-02 Impact factor: 4.044